The open index of psychedelic research

Open datasets, papers, preregistrations, and trials from across psychedelic science.

11,281 records6 sources
Showing 1,369–1,392 of 11,281
PreregistrationPsilocybin

Retreat-based Investigation of Survivor Experiences with Psilocybin (Project RISE): Primary Outcomes Paper

OSF2026
ArticleDMT

Inhaled Mebufotenin (GH001) for Adult Patients With Postpartum Depression: A Phase 2a Open-Label Clinical Trial.

Johnson M, Aceves Baldo P, Arbe E +16

Europe PMC2026
ArticleKetamine

Investigation of Esketamine Administration During Surgical Procedures for the Alleviation of Postoperative Anxiety and Depression in Adolescent Patients: A Randomized Controlled Trial.

Li Y, Zhao K, Cao P +3

Europe PMC2026
ProjectKetamine

Ketamine-Assisted Narrative Intervention (KANI) for Veterans with Chronic Low Back Pain and Co-Occurring Depression: Treatment Manual for Narrative Intervention Component

OSF2026
ArticleKetamine

Esketamine Accelerates Emergence from Propofol Anesthesia in Patients Undergoing Laparoscopic Gynecological Surgery: A Randomized Controlled Trial.

Qi Y, Ren Y, Xu W +5

Europe PMC2026
ArticlePsilocybin

Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World Implementation.

Dorval M, Audet-Croteau V, Chang SL +6

Europe PMC2026
ArticleKetamine

Esketamine-propofol combination for colonoscopy sedation: addressing the limitations of propofol monotherapy.

Wasti SA, Wasti A, Abdullah MU +2

Europe PMC2026
ArticleKetamine

Perioperative esketamine for prevention of postoperative sleep disturbance after anesthesia: a systematic review and meta-analysis of randomized controlled trials.

Zeng J, Li J, Zhou Y +3

Europe PMC2026
ArticlePsychedelics

Exploring meaning in culture: Insights from meaning-centered psychotherapy in Aotearoa, New Zealand.

Clayden C, Wells A, Applebaum AJ +1

Europe PMC2026
PreprintKetamine

Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 Adults

Carter D, Reardon I, Swain J +1

Europe PMC2026
ArticlePsilocybin

Time to embrace the whole: considering the replacement of psilocybin with <i>Psilocybe</i> spp. in psychedelic research and therapy.

Ona G, Llagostera C, Alvarez O +3

Europe PMC2026
ArticleKetamine

Psychedelic-Assisted Interventions in Palliative Care: A Narrative Overview and Critical Evaluation.

Soares DA, Campolina AG

Europe PMC2026
ArticleKetamine

Association of Esketamine use with mortality and clinical outcomes in patients with cancer-related depression: A target trial emulation.

Chen JP, Hsu CW, Fang YY +4

Europe PMC2026
ArticleKetamine

Increasing dose of esketamine for supplemental analgesia after complex spinal fusion surgery: a randomized and double-blind trial.

Guo ZM, Cui F, Zhang Y +2

Europe PMC2026
PreprintKetamine

Preliminary Non-Randomized Clinical Trial of Subcutaneous Esketamine in Treatment-Resistant Depression: Exploring Adjunctive Effects of Ketamine-Assisted Psychotherapy

Varela YM, Cavalcanti-Ribeiro P, de Sousa GM +18

Europe PMC2026
ArticleKetamine

A Study on the ED90 of Esketamine Combined with Ropivacaine for Early Epidural Analgesia During the First Stage of Labor in Nulliparous Women: A Randomized, Sequential Dose-Finding Trial.

Lin X, Tu Y, Qiu P +3

Europe PMC2026
ArticleKetamine

Ciprofol-Esketamine Versus Ciprofol-Remifentanil in Hysteroscopic Endometrial Polypectomy: A Randomized Controlled Trial.

Zhang Z, Wang Z, Gong W +3

Europe PMC2026
PreprintPsychedelics

Tripping on context: Characteristics and predictors of placebo and nocebo psychedelic effects

Stein MV, Butler M, Chapman S +2

Europe PMC2026
ArticlePsychedelics

Priorities for psychedelic research among people who use psychedelics.

Kruger DJ, Czerew A, Farquhar L +9

Europe PMC2026
ArticleIbogaine

Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.

Kervadec E, Bezo A, Serreau R +5

Europe PMC2026
ArticleMDMA

Psychodynamic Perspectives on Psychedelic States and Treatment Contexts: A Conceptual and Clinical Introduction.

Modlin NL, Elek Z, Maggio C +5

Europe PMC2026
ArticlePsilocybin

Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomized [<sup>18</sup>F]FDG-PET study.

Egger K, Bozsak R, Aicher HD +9

Europe PMC2026
ArticlePsilocybin

Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian Lens.

Miller CWT, Kozak Z

Europe PMC2026
ArticlePsilocybin

Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland.

Kelly JR, Sheridan C, Iusan P +10

Europe PMC2026